The MPTP/Probenecid Model of Progressive Parkinsons Disease
Parkinson’s disease (PD) is characterized by a progressive degeneration of dopamine (DA) neurons and a chronic loss of motor functions. The investigation of progressive degenerative mechanisms and possible neuroprotective approaches for PD depends upon the development of an experimental animal model that reproduces the neuropathology observed in humans. This chapter describes the generation of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid (MPTPp) chronic mouse model of PD. This model displays key features of PD, including impairment of motor and olfactory functions associated with partial loss of tyrosine hydroxylase-positive neurons and DA levels in the brain. The MPTPp mouse model provides an important tool for the study of mechanisms contributing to the pathological dysfunction of PD at the cellular and whole animal level.
- Analysis of Vesicular Trafficking in Primary Neurons by Live Imaging
- Label-Free Affinity Biosensors Based on Electrochemical Impedance Spectroscopy
- EEG, Evoked Potential, and Extracellular Single-Unit Recordings In Vivo
- Adeno-Associated Viral Gene Delivery in Neurodegenerative Disease
- Selection of Optimal Pulse Sequences for fMRI
- Brain Microdialysis in Freely Moving Animals
- Saccharin Preference in Rats: Relation to Impulsivity and Drug Abuse
- Morphological Approaches to the Anatomical Dissection of Neuronal Circuits
- Site-Directed Mutagenesis and Chimeric Receptors in the Study of Receptor-Ligand Binding
- Tomato Lectin Histochemistry for Microglial Visualization